Mariko Asaoka
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 24, 2022
NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation.Rongrong Wu, Arya Mariam Roy, Yoshihisa Tokumaru
|Jan 06, 2021
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future.Mariko Asaoka, Shipra Gandhi, Takashi Ishikawa
|Oct 07, 2020
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.Masanori Oshi, Yoshihisa Tokumaru, Mariko Asaoka
|Feb 07, 2020
Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate.Hideo Takahashi, Mariko Asaoka, Li Yan
Pageof 1
